OSUR News and Press, OraSure Technologies Inc. From 08/03/23

InteliSwab ® test revenue of $47.5 million in Q2 Q2 Core revenue of $37.9 million grew 4% sequentially and 3% year-over-year Q2 GAAP EPS of $(0.07); Q2 Non-GAAP EPS of $0.09 Grew cash balance to $185.9 million as o f June 30, 2023 InteliSwab ...

BETHLEHEM, Pa., July 20, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2023 second quarter financial results and certain business developments for 5:00 pm ET on Thursday, August 3, 2023. A webcast of the confer...

BETHLEHEM, Pa., July 20, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, announced today the election of Robert W. McMahon, CMA, MBA, to the Com...

BETHLEHEM, Pa., June 13, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and at-home diagnostic testing, as well as non-invasive self-sampling technologies and microbiome-focused biocomputational solutions, announced today that a major health e...

2023-05-17 05:47:01 ET Summary OraSure came in with another strong quarter with upsides against the consensus at the top and bottom lines. The firm is concentrating heavily on capital allocation and will close its overseas InteliSwab production lines. The market expects strong...

2023-05-15 17:57:27 ET Summary Today, we take our first look at OraSure Technologies, Inc., which has seen a huge and recent surge of revenues. However, this was almost entirely due to Covid-related sales which are projected to fall dramatically in the quarters ahead. Manageme...

2023-05-10 22:50:23 ET OraSure Technologies, Inc. (OSUR) Q1 2023 Earnings Conference Call May 10, 2023 05:00 PM ET Company Participants Scott Gleason - Head of Investor Relations Carrie Manner - President & Chief Executive Officer Ken McGrath - Chief Financia...

2023-05-10 16:57:45 ET OraSure Technologies press release ( NASDAQ: OSUR ): Q1 Non-GAAP EPS of $0.47 beats by $0.31 . Revenue of $154.96M (+128.9% Y/Y) beats by $28.39M . Gross margins increase 200 basis points sequentially despite mix/pricing headwinds. ...

InteliSwab ® test revenue of $118.3 million in Q1, up 33% sequentially; Company delivers cost savings and begins to taper InteliSwab ® test production and expenses Gross margins increase 200 basis points sequentially despite mix/pricing headwinds ...

BETHLEHEM, Pa., May 03, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2023 first quarter financial results and certain business developments for 5:00 p.m. ET (2:00 p.m. PT) on Wednesday, May 10, 2023. May 10, 2...